NASDAQ:ALGN - Align Technology Stock Price, Forecast & News

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) posted its earnings results on Wednesday, January, 29th. The medical equipment provider reported $1.53 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.13. The medical equipment provider had revenue of $649.80 million for the quarter, compared to analysts' expectations of $646.75 million. The company's revenue for the quarter was up 21.7% on a year-over-year basis. During the same period last year, the business posted $1.20 EPS. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, April 22nd 2020. View Earnings Estimates for Align Technology.

Align Technology issued an update on its first quarter earnings guidance on Wednesday, January, 29th. The company provided earnings per share guidance of $1.19-$1.28 for the period, compared to the Thomson Reuters consensus estimate of $1.42. The company issued revenue guidance of $615-$630 million, compared to the consensus revenue estimate of $656.29 million.

11 Wall Street analysts have issued 12 month price objectives for Align Technology's stock. Their forecasts range from $200.00 to $360.00. On average, they expect Align Technology's share price to reach $270.09 in the next year. This suggests that the stock has a possible downside of 1.8%. View Analyst Price Targets for Align Technology.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Align Technology.

Headlines about ALGN stock have trended neutral recently, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Align Technology earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Align Technology.

Align Technology saw a decline in short interest during the month of January. As of January 31st, there was short interest totalling 3,430,000 shares, a decline of 8.8% from the January 15th total of 3,760,000 shares. Based on an average daily volume of 768,100 shares, the short-interest ratio is currently 4.5 days. Currently, 4.8% of the company's stock are short sold. View Align Technology's Current Options Chain.

Some companies that are related to Align Technology include Atrion (ATRI), Anika Therapeutics (ANIK), Antares Pharma (ATRS), Cerus (CERS), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Endologix (ELGX), Haemonetics (HAE), ICU Medical (ICUI), Meridian Bioscience (VIVO), Merit Medical Systems (MMSI), Neogen (NEOG), OraSure Technologies (OSUR), Quidel (QDEL) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Micron Technology (MU), Adobe (ADBE), Paypal (PYPL), Visa (v), salesforce.com (CRM), Boeing (BA) and Mastercard (MA).

Align Technology's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Edgewood Management LLC (5.96%), State Street Corp (3.93%), Sands Capital Management LLC (3.71%), Polen Capital Management LLC (3.59%), Renaissance Technologies LLC (3.31%) and Bank of New York Mellon Corp (1.54%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Simon Beard, Sreelakshmi Kolli, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler and Yuval Shaked. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including UBS Asset Management Americas Inc., Echo Street Capital Management LLC, Goldman Sachs Group Inc., AQR Capital Management LLC, Logan Capital Management Inc., Jennison Associates LLC, Factory Mutual Insurance Co. and Bank of New York Mellon Corp. Company insiders that have sold Align Technology company stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Greg J Santora, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Warren S Thaler and Yuval Shaked. View Insider Buying and Selling for Align Technology.

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Veritas Investment Management LLP, Champlain Investment Partners LLC, Amundi Pioneer Asset Management Inc., FMR LLC, Morningstar Investment Services LLC, Bessemer Group Inc. and Eagle Asset Management Inc.. Company insiders that have bought Align Technology stock in the last two years include Joseph M Hogan and Vamsi Mohan Raj Pudipeddi. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $274.95.